Growth NormalizationNext year, growth is expected to normalize to about 2x the market rate, which is in line with the past 4 years, suggesting a potential slowdown compared to the current growth rate.
Revenue And EBITDA Margins4Q implied revenue growth of 13% at midpoint and adj-EBITDA margin of 47.4% is a step-down from the last two quarter levels, indicating potential normalization.
Revenue GrowthThere is an element of conservatism in the FY4Q'25 guidance, with expected year-over-year revenue growth of roughly 11%.